ANTARES PHARMA, INC.

Smart Drug Delivery Systems Market Poised for 17% Growth as Chronic Disease Management Evolves

a month ago

• The global smart drug delivery systems market reached $12 billion in 2024 and is projected to grow at a CAGR of 17% through 2034, driven by rising chronic disease prevalence and technological advancements. • Connected inhalers are gaining significant traction for respiratory and neurological conditions, with recent partnerships like Modivcare and Tenovi deploying Adherium's Hailie smart inhalers to improve patient care. • Injectable smart delivery systems dominated the market with a $7.6 billion valuation in 2024, while North America leads regional adoption with $5.5 billion in revenue, expected to reach $22.2 billion by 2034.